Sweden· SE-19990618000029
Viramune 50 mg/5 ml Oral suspension
A medicinal product containing nevirapine, registered in Sweden by Boehringer Ingelheim International GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Nevirapine
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19990618000029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nevirapine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayNevirapine aurobindoAurobindo
- SpainVIRAMUNE 50 mg/5 ml SUSPENSION ORALBoehringer Ingelheim International Gmbh
- FinlandViramuneBoehringer Ingelheim International GmbH
- FranceVIRAMUNE 50 mg/5 ml, suspension buvableBOEHRINGER INGELHEIM INTERNATIONAL
- IcelandViramuneBoehringer Ingelheim International GmbH*
- NetherlandsViramune 50 mg/5 ml Oral Suspension, suspensie voor oraal gebruikBoehringer Ingelheim Pharma GmbH & Co. KG
- BelgiumViramune 50 mg/5 mlBoehringer Ingelheim International
- PolandViramuneBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Nevirapin Viatris
- Belgium · Nevirapine Viatris
- Germany · Nevirapin Abdi, Nevirapin Aurobindo
- Denmark · Nevirapine Medical Valley, Nevirapine Viatris
- Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
- Finland · Nevirapine Viatris
- France · Nevirapine Arrow Lab, Nevirapine Cristers
- United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
- Greece · Nevirapine Vocate
- Iceland · Viramune
- Italy · Nevirapina Aurobindo, Nevirapina Mylan
- Liechtenstein · Viramune
- Luxembourg · Nevirapine Viatris
- Netherlands · Nevirapine Accord, Nevirapine Amarox
- Norway · Viramune
- Portugal · Nevirapina Accord, Nevirapina Aurovitas
- Romania · Nevirapina Accord, Nevirapină Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4382abf4-2fc8-4eee-8486-1e4813d55977 GET /v1/drugs/4382abf4-2fc8-4eee-8486-1e4813d55977?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "19990618000029",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990618000029",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/viramune-epar-product-information_sv.pdf"
}See everything about nevirapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.